129 related articles for article (PubMed ID: 6521115)
1. [The role of the activated coagulation time (ACT) in open heart surgery--comparison between children and adult patients].
Ohmi M; Tsuboi H; Furukawa S; Mohri H; Seo K
Kyobu Geka; 1984 Nov; 37(12):945-8. PubMed ID: 6521115
[No Abstract] [Full Text] [Related]
2. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
Dercksen SJ; Linssen GH
Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
Dercksen SJ; Linssen GH
Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the activated clotting time to control heparin andprotamine dosage in open-heart surgery.
Arkin CF; Shahsavari M; Copeland BE; Kim A
J Thorac Cardiovasc Surg; 1978 May; 75(5):790-2. PubMed ID: 642581
[No Abstract] [Full Text] [Related]
5. [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].
Khodas MIa; Piatnitskaia GKh; Savina ME; Smirnova LA
Anesteziol Reanimatol; 1989; (2):11-5. PubMed ID: 2742179
[TBL] [Abstract][Full Text] [Related]
6. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
[TBL] [Abstract][Full Text] [Related]
7. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
[No Abstract] [Full Text] [Related]
8. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
Shiao K
Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
[No Abstract] [Full Text] [Related]
9. [Our method and concept concerning the activated clotting time (ACT) during cardiopulmonary bypass].
Watanabe T; Abe T; Iyomasa Y
Kokyu To Junkan; 1983 Jul; 31(7):781-6. PubMed ID: 6658213
[No Abstract] [Full Text] [Related]
10. Clinical experience with activated clotting time (ACT) controlled heparinization in open heart surgery.
Albrechtsen OK; Stenbjerg S; Berg E
Thorac Cardiovasc Surg; 1982 Apr; 30(2):109-12. PubMed ID: 6179241
[No Abstract] [Full Text] [Related]
11. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
12. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
[TBL] [Abstract][Full Text] [Related]
13. Control of heparin therapy in open-heart surgery.
Jaberi M; Bell WR; Benson DW
J Thorac Cardiovasc Surg; 1974 Jan; 67(1):133-41. PubMed ID: 4808908
[No Abstract] [Full Text] [Related]
14. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
Dement'eva II; Savina ME; Piatnitskaia GKh
Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
[No Abstract] [Full Text] [Related]
15. [A computerized method for the administration of heparin and protamine during open-heart surgery].
Isshiki A; Sakaguchi Y; Kubota K; Ikeda T
Masui; 1984 Dec; 33(12):1323-8. PubMed ID: 6530734
[No Abstract] [Full Text] [Related]
16. Management of blood loss and heparin rebound following cardiopulmonary bypass.
Pifarre R; Sullivan HJ; Montoya A; Bakhos M; Grieco J; Foy BK; Blakeman B
Semin Thromb Hemost; 1989 Apr; 15(2):173-7. PubMed ID: 2787532
[No Abstract] [Full Text] [Related]
17. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
Kim YS; Murkin JM; Adams SJ
Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
[TBL] [Abstract][Full Text] [Related]
18. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
[TBL] [Abstract][Full Text] [Related]
19. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time].
Evora PR; Brasil JC; Otaviano AG; Margarido EA; Ribeiro PJ; Reis CL; Silva JR; Secches AL
Arq Bras Cardiol; 1981 Aug; 37(2):89-93. PubMed ID: 7348180
[No Abstract] [Full Text] [Related]
20. Heparin rebound. Studies in patients and volunteers.
Ellison N; Beatty CP; Blake DR; Wurzel HA; MacVaugh H
J Thorac Cardiovasc Surg; 1974 May; 67(5):723-9. PubMed ID: 4823307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
